Home > Boards > US Listed > Biotechs > PharmaCyte Biotech Inc. (PMCB)

Joep please feel free to post your opinion

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
longboarder7892 Member Profile
 
Followed By 20
Posts 2,223
Boards Moderated 4
Alias Born 12/06/17
160x600 placeholder
PharmaCyte Biotech to Present at H.C. Wainwright BioConnect Conference Business Wire - 1/6/2022 9:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/4/2022 10:44:02 AM
PharmaCyte Biotech Study Proves Capsule Material Is Not Toxic For Encapsulated Cells Business Wire - 1/4/2022 9:00:00 AM
PharmaCyte completes stability study as part of process to get clinical hold lifted Seeking Alpha - 12/28/2021 9:41:47 AM
PharmaCyte Biotech Successfully Completes 36 Month Master Cell Bank Stability Study Business Wire - 12/28/2021 9:00:00 AM
PharmaCyte Biotech reports FQ2 results Seeking Alpha - 12/15/2021 9:08:54 AM
PharmaCyte Biotech Reports Second Quarter 2021 Financial Results and Operational Highlights Business Wire - 12/15/2021 9:00:00 AM
Analysts Offer Insights on Consumer Goods Companies: Aspen Group (ASPU) and PharmaCyte Biotech (PMCB) TipRanks - 12/15/2021 6:16:39 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 12/14/2021 5:17:29 PM
PharmaCyte Biotech Successfully Completes Cytochrome P450 Site of Integration DNA Sequencing Assay Business Wire - 12/8/2021 10:16:00 AM
H.C. Wainwright Keeps a Hold Rating on PharmaCyte Biotech (PMCB) TipRanks - 11/30/2021 12:05:16 PM
PharmaCyte Biotech Launches Malignant Ascites Program with Commencement of Pivotal Preclinical Study Business Wire - 11/30/2021 1:05:00 AM
PharmaCyte Biotech Announces Cell Encapsulation Technology Material Does Not Cause Skin Irritation Business Wire - 11/12/2021 9:00:00 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 11/8/2021 6:01:27 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 11/4/2021 7:39:35 AM
PharmaCyte Biotech Announces Encapsulation Material Does Not Alter Cellular DNA Business Wire - 9/27/2021 9:00:00 AM
PharmaCyte Biotech Releases More Positive Results From FDA-Required Biocompatibility Tests Business Wire - 9/21/2021 9:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 9/14/2021 8:02:08 AM
PharmaCyte Biotech to Participate in H.C. Wainwright 23rd Annual Global Investment Conference Business Wire - 9/8/2021 9:00:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/3/2021 7:20:53 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 9/1/2021 6:04:10 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/31/2021 6:25:24 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/31/2021 6:24:54 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/31/2021 6:24:23 PM
PharmaCyte Biotech Establishes 18-Month Shelf Life for Clinical Trial Product in Ongoing Stability Study Business Wire - 8/31/2021 9:20:00 AM
longboarder7892   Wednesday, 09/08/21 04:26:34 PM
Re: joep1 post# 143598
Post # of 144231 
Joep please feel free to post your opinion and any DD you find on PMCB. Welcome to the board. To learn more about PharmaCyte’s pancreatic cancer treatment and how it works inside the body to treat locally advanced inoperable pancreatic cancer, we encourage you to watch the company’s documentary video complete with medical animations at: https://www.PharmaCyte.com/Cancer

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences